Managing Nocturnal Hypoglycemia with Ryzodeg Downtitration

Understanding Ryzodeg and Nocturnal Hypoglycemia

Ryzodeg is a combination insulin product containing ultra-long-acting basal insulin degludec and rapid-acting insulin aspart, with the American Diabetes Association recommending its use for patients with type 1 and type 2 diabetes 1
Nocturnal hypoglycemia is a common concern with insulin therapy, typically peaking between midnight and 6:00 AM, and increases the risk for subsequent hypoglycemic events, according to the American Association of Clinical Endocrinologists 2
Nocturnal hypoglycemia increases the risk for subsequent hypoglycemic events, with a study by the Endocrine Society showing that patients with nocturnal hypoglycemia are more likely to experience severe hypoglycemia 2, 3

For a patient experiencing ongoing nocturnal hypoglycemia while on Ryzodeg, the dose should be reduced by 10-20% to approximately 16-18 units, with subsequent adjustments based on blood glucose monitoring, as recommended by the American College of Endocrinology 4, 5
For severe or recurrent hypoglycemia, consider a 20% reduction in Ryzodeg dose, while for mild hypoglycemia, consider a 10% reduction, according to the European Association for the Study of Diabetes 1, 4

Monitor fasting blood glucose daily for at least one week, with a target fasting glucose range of 90-150 mg/dL, as recommended by the International Diabetes Federation 1
If more than 50% of fasting glucose values remain above target after one week, increase the Ryzodeg dose by 2 units, while if two or more fasting glucose values per week are below 80 mg/dL, decrease the dose by an additional 2 units, according to the American Diabetes Association 1

Consider changing the timing of Ryzodeg administration from dinner to earlier in the day if nocturnal hypoglycemia persists, with the Endocrine Society recommending consistent timing of administration to maintain predictable insulin action 1, 6
Evaluate the carbohydrate content of the evening meal and consider adding a bedtime snack containing carbohydrates if hypoglycemia persists despite dose reduction, as recommended by the Academy of Nutrition and Dietetics 6
Avoid alcohol consumption in the evening, which increases the risk of hypoglycemia, according to the National Institute of Diabetes and Digestive and Kidney Diseases 6

If hypoglycemia persists despite dose reduction, consider switching to a different insulin regimen with separate basal and bolus components, evaluating for overbasalization, or assessing for changes in physical activity patterns or renal function, as recommended by the American Association of Clinical Endocrinologists 7, 8, 2, 3

Instruct the patient to check blood glucose at bedtime, 3:00 AM, and upon waking for several days after dose adjustment, with the American College of Endocrinology recommending education on symptoms of nocturnal hypoglycemia 2
Ensure the patient has glucagon available for emergency hypoglycemia treatment, as recommended by the Endocrine Society 8

Schedule follow-up within 1-2 weeks to assess response to dose adjustment, with the International Diabetes Federation recommending review of blood glucose logs to identify patterns and make further adjustments as needed 4
Consider additional medication changes if glycemic targets cannot be achieved without hypoglycemia, according to the American Diabetes Association 7